[Interview] ICCPP Group: “Five Sense” Vaporization Technology, The Lifeline is Innovation

Innovation
Jun.22.2022
[Interview] ICCPP Group: “Five Sense” Vaporization Technology, The Lifeline is Innovation
2FIRSTS interviewed Jane Lu, the Brand Director of ICCPP Group to reveal the answer.

 Just like the story "other family’s child", ICCPP is the gifted student who has never been partial to subjects, and had handed over full marks all the way on the road of enterprise development. Where does ICCPP’s strong strength come from? What's special about the philosophy of ICCPP’s operators? 2FIRSTS interviewed Jane Lu, the Brand Director of ICCPP Group to reveal the answer.

 

Bringing a Multi-Dimensional Experience to the "Five Senses"

 

In 2014, ICCPP founder Zhao Guanyun, founded ICCPP Technology Co., Ltd. in Shenzhen, focusing on the development of electronic vaporization chips. In 2017, through in-depth market research, the founder team of ICCPP realized that only self-operated brands can get closer to users and better meet customer needs. In that year, the founder team established its own brand, and successfully entered the international market.

 

The transformation of the company is a major event. Of course, it has experienced doubts, but the founder team has a firm strategic direction of its own brand, and started ICCPP’s new story on path.

 

ICCPP brand director, Jane Lu, interprets their products with a unique perspective. She said: "Many people will not see it as high-tech, but as the opposite. Electronic vaporization uses the 'five senses' (taste, vision, hearing, smell, touch) as the starting point to bring consumers a multi-dimensional product experience. The design and development of a product contains cutting-edge technologies in different fields such as basic materials, electronic chips, and life sciences. Consumer may not see it, but technology is in every fiber and process.”

 

ICCPP’s "customer-centered" business philosophy, as well as its comprehensive layout in technological innovation, product development, intelligent manufacturing, and independent brand management, are the key factors to maintaining their high growth. Jane Lu said: "Every company that makes products and serves users down-to-earth will have a place to stand. Only in this way can our doubts be cleared, and our future gradually become brighter."

 

Eight years after its establishment, ICCPP products have been sold in more than 70 countries and regions around the world. The group has 6 branches each in United States, Canada, Germany, the United Kingdom, France, and Indonesia. At present, it has formed a global headcount of more than 6,000 people, and has an independent R&D team of more than 500 people, including more than ten doctors. They have the basic pre-research capabilities with 4 research institutes. Their operations network stretch over 7 major branches and 6 manufacturing centers. Recently, a scientific paper by ICCPP was also published in the Journal of Advanced Research in Fluid Mechanics and Thermal Sciences.

 

Innovation is the Lifeline

 

In 2017, ICCPP created the ignition speed record of 0.0025 second suction at that time with their innovative R&D. Later, each generation of their products had distinctive highlights, and directly or indirectly led the innovation and change of the industry. In this regard, ICCPP’s founder team once said modestly: "Innovation is not simply the product of competition, but the inevitable result of the positive development of the industry."

 

 

In 2020, ICCPP developed into a TOP tier enterprise in the industry. In the past few years, ICCPP had closely carried out innovative materials research in cooperation with many well-known domestic universities. They built a forward-looking R&D system integrating production, learning and research, and built a global compliance team as well as four major research institutions at crazy speeds. Presently, ICCPP has applied for more than 1,000 patents in total and now has the capabilities of the whole industry chain structure.

 

Product innovation has always been the lifeline of ICCPP Technology. Jane Lu introduced: "We built the world's fastest ignition equipment and introduced 'second suction' to the industry as a key indicator. We pioneered a common standard interface for products, redefining the industry's interface manufacturing standards. We developed Gene Tree micro-crystalline Ceramic core, with 0 friction and 0 dust to satisfy users' pure suction experience." ICCPP ultimate goal is to realize "vaporization core standardization, vaporization interface standardization, and vapor equipment integration". As one of the leaders in the field of vapor technology and new material technology, ICCPP will continue to deepen the field of electronic vapor technology in the future, and continue to play a benchmarking role in the industry.

Russian Strikes Destroy JTI and Imperial Brands Ukraine Warehouses, With Losses Reaching Tens of Millions of Hryvnias
Russian Strikes Destroy JTI and Imperial Brands Ukraine Warehouses, With Losses Reaching Tens of Millions of Hryvnias
According to Ukrainska Pravda, Russian strikes on the Kyiv region during the night of Aug. 4-5, 2026, damaged warehouses storing products of Japan Tobacco International (JTI) and Imperial Brands Ukraine. JTI said a finished goods warehouse in Kyiv Oblast was destroyed, with no employees injured, and that it did not expect disruptions to retail supplies. Imperial Brands Ukraine said products stored at warehouses of distributors and retail partners were affected and estimated losses from the strikes at “tens of millions of Ukrainian hryvnias” (roughly hundreds of thousands of U.S. dollars).
JTI
Aug.07
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
British e-liquid manufacturer Riot Labs has introduced a fictional “candidate” called Riot Man around the Clacton parliamentary by-election, seeking to mobilize consumers and retailers against parts of the UK government’s proposed restrictions on vape packaging, device appearance and retail displays. Riot Man is not listed as an official candidate.
Aug.12
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives